Global Pulmonary Hypertension Drug Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Publisher Name :
Date: 12-Sep-2018
No. of pages: 123

Pulmonary hypertension is a state of the body in which the blood pressure rises in the arteries. Pulmonary hypertension drugs belong to the class of anti-hypertensives drugs that are used specifically to treat pulmonary hypertension. In addition, this class of drugs treats other life-threatening diseases such as arrhythmias, ryanoids syndrome, cephalagra, and angina.

Scope of the Report:

This report focuses on the Pulmonary Hypertension Drug in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

The worldwide market for Pulmonary Hypertension Drug is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

- GlaxoSmithKline plc

- Novartis AG

- Merck & Co., Inc.

- Abbott Laboratories

- Boehringer Ingelheim GmbH

- AstraZeneca plc

- F. Hoffmann-La Roche AG

- Teva Pharmaceutical Industries Ltd.

- Vectura Group plc

- Pfizer Inc.

Market Segment by Regions, regional analysis covers

- North America (United States, Canada and Mexico)

- Europe (Germany, France, UK, Russia and Italy)

- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

- South America (Brazil, Argentina, Colombia etc.)

- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

- Prostacyclin and Prostacyclin Analogs

- Endothelin Receptor Antagonists

- Phosphodiesterase-5 Inhibitors

- Soluble Guanylate Cyclase Stimulators

Market Segment by Applications, can be divided into

- Early-stage Drug Candidates (Phase I & Phase II)

- Late-stage Drug Candidates (Phase III & Registration Phase)

There are 15 Chapters to deeply display the global Pulmonary Hypertension Drug market.

Chapter 1, to describe Pulmonary Hypertension Drug Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Pulmonary Hypertension Drug, with sales, revenue, and price of Pulmonary Hypertension Drug, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Pulmonary Hypertension Drug, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Pulmonary Hypertension Drug market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Pulmonary Hypertension Drug sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Global Pulmonary Hypertension Drug Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Table of Contents
1 Market Overview
1.1 Pulmonary Hypertension Drug Introduction
1.2 Market Analysis by Type
1.2.1 Prostacyclin and Prostacyclin Analogs
1.2.2 Endothelin Receptor Antagonists
1.2.3 Phosphodiesterase-5 Inhibitors
1.2.4 Soluble Guanylate Cyclase Stimulators
1.3 Market Analysis by Applications
1.3.1 Early-stage Drug Candidates (Phase I & Phase II)
1.3.2 Late-stage Drug Candidates (Phase III & Registration Phase)
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 GlaxoSmithKline plc
2.1.1 Business Overview
2.1.2 Pulmonary Hypertension Drug Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 GlaxoSmithKline plc Pulmonary Hypertension Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Novartis AG
2.2.1 Business Overview
2.2.2 Pulmonary Hypertension Drug Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Novartis AG Pulmonary Hypertension Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Merck & Co., Inc.
2.3.1 Business Overview
2.3.2 Pulmonary Hypertension Drug Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Merck & Co., Inc. Pulmonary Hypertension Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Abbott Laboratories
2.4.1 Business Overview
2.4.2 Pulmonary Hypertension Drug Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Abbott Laboratories Pulmonary Hypertension Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Boehringer Ingelheim GmbH
2.5.1 Business Overview
2.5.2 Pulmonary Hypertension Drug Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Boehringer Ingelheim GmbH Pulmonary Hypertension Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 AstraZeneca plc
2.6.1 Business Overview
2.6.2 Pulmonary Hypertension Drug Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 AstraZeneca plc Pulmonary Hypertension Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 F. Hoffmann-La Roche AG
2.7.1 Business Overview
2.7.2 Pulmonary Hypertension Drug Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 F. Hoffmann-La Roche AG Pulmonary Hypertension Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Teva Pharmaceutical Industries Ltd.
2.8.1 Business Overview
2.8.2 Pulmonary Hypertension Drug Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Teva Pharmaceutical Industries Ltd. Pulmonary Hypertension Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Vectura Group plc
2.9.1 Business Overview
2.9.2 Pulmonary Hypertension Drug Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Vectura Group plc Pulmonary Hypertension Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Pfizer Inc.
2.10.1 Business Overview
2.10.2 Pulmonary Hypertension Drug Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Pfizer Inc. Pulmonary Hypertension Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Pulmonary Hypertension Drug Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Pulmonary Hypertension Drug Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Pulmonary Hypertension Drug Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Pulmonary Hypertension Drug Manufacturer Market Share in 2017
3.3.2 Top 6 Pulmonary Hypertension Drug Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Pulmonary Hypertension Drug Market Analysis by Regions
4.1 Global Pulmonary Hypertension Drug Sales, Revenue and Market Share by Regions
4.1.1 Global Pulmonary Hypertension Drug Sales and Market Share by Regions (2013-2018)
4.1.2 Global Pulmonary Hypertension Drug Revenue and Market Share by Regions (2013-2018)
4.2 North America Pulmonary Hypertension Drug Sales and Growth Rate (2013-2018)
4.3 Europe Pulmonary Hypertension Drug Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Pulmonary Hypertension Drug Sales and Growth Rate (2013-2018)
4.5 South America Pulmonary Hypertension Drug Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Pulmonary Hypertension Drug Sales and Growth Rate (2013-2018)
5 North America Pulmonary Hypertension Drug by Countries
5.1 North America Pulmonary Hypertension Drug Sales, Revenue and Market Share by Countries
5.1.1 North America Pulmonary Hypertension Drug Sales and Market Share by Countries (2013-2018)
5.1.2 North America Pulmonary Hypertension Drug Revenue and Market Share by Countries (2013-2018)
5.2 United States Pulmonary Hypertension Drug Sales and Growth Rate (2013-2018)
5.3 Canada Pulmonary Hypertension Drug Sales and Growth Rate (2013-2018)
5.4 Mexico Pulmonary Hypertension Drug Sales and Growth Rate (2013-2018)
6 Europe Pulmonary Hypertension Drug by Countries
6.1 Europe Pulmonary Hypertension Drug Sales, Revenue and Market Share by Countries
6.1.1 Europe Pulmonary Hypertension Drug Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Pulmonary Hypertension Drug Revenue and Market Share by Countries (2013-2018)
6.2 Germany Pulmonary Hypertension Drug Sales and Growth Rate (2013-2018)
6.3 UK Pulmonary Hypertension Drug Sales and Growth Rate (2013-2018)
6.4 France Pulmonary Hypertension Drug Sales and Growth Rate (2013-2018)
6.5 Russia Pulmonary Hypertension Drug Sales and Growth Rate (2013-2018)
6.6 Italy Pulmonary Hypertension Drug Sales and Growth Rate (2013-2018)
7 Asia-Pacific Pulmonary Hypertension Drug by Countries
7.1 Asia-Pacific Pulmonary Hypertension Drug Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Pulmonary Hypertension Drug Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Pulmonary Hypertension Drug Revenue and Market Share by Countries (2013-2018)
7.2 China Pulmonary Hypertension Drug Sales and Growth Rate (2013-2018)
7.3 Japan Pulmonary Hypertension Drug Sales and Growth Rate (2013-2018)
7.4 Korea Pulmonary Hypertension Drug Sales and Growth Rate (2013-2018)
7.5 India Pulmonary Hypertension Drug Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Pulmonary Hypertension Drug Sales and Growth Rate (2013-2018)
8 South America Pulmonary Hypertension Drug by Countries
8.1 South America Pulmonary Hypertension Drug Sales, Revenue and Market Share by Countries
8.1.1 South America Pulmonary Hypertension Drug Sales and Market Share by Countries (2013-2018)
8.1.2 South America Pulmonary Hypertension Drug Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Pulmonary Hypertension Drug Sales and Growth Rate (2013-2018)
8.3 Argentina Pulmonary Hypertension Drug Sales and Growth Rate (2013-2018)
8.4 Colombia Pulmonary Hypertension Drug Sales and Growth Rate (2013-2018)
9 Middle East and Africa Pulmonary Hypertension Drug by Countries
9.1 Middle East and Africa Pulmonary Hypertension Drug Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Pulmonary Hypertension Drug Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Pulmonary Hypertension Drug Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Pulmonary Hypertension Drug Sales and Growth Rate (2013-2018)
9.3 UAE Pulmonary Hypertension Drug Sales and Growth Rate (2013-2018)
9.4 Egypt Pulmonary Hypertension Drug Sales and Growth Rate (2013-2018)
9.5 Nigeria Pulmonary Hypertension Drug Sales and Growth Rate (2013-2018)
9.6 South Africa Pulmonary Hypertension Drug Sales and Growth Rate (2013-2018)
10 Global Pulmonary Hypertension Drug Market Segment by Type
10.1 Global Pulmonary Hypertension Drug Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Pulmonary Hypertension Drug Sales and Market Share by Type (2013-2018)
10.1.2 Global Pulmonary Hypertension Drug Revenue and Market Share by Type (2013-2018)
10.2 Prostacyclin and Prostacyclin Analogs Sales Growth and Price
10.2.1 Global Prostacyclin and Prostacyclin Analogs Sales Growth (2013-2018)
10.2.2 Global Prostacyclin and Prostacyclin Analogs Price (2013-2018)
10.3 Endothelin Receptor Antagonists Sales Growth and Price
10.3.1 Global Endothelin Receptor Antagonists Sales Growth (2013-2018)
10.3.2 Global Endothelin Receptor Antagonists Price (2013-2018)
10.4 Phosphodiesterase-5 Inhibitors Sales Growth and Price
10.4.1 Global Phosphodiesterase-5 Inhibitors Sales Growth (2013-2018)
10.4.2 Global Phosphodiesterase-5 Inhibitors Price (2013-2018)
10.5 Soluble Guanylate Cyclase Stimulators Sales Growth and Price
10.5.1 Global Soluble Guanylate Cyclase Stimulators Sales Growth (2013-2018)
10.5.2 Global Soluble Guanylate Cyclase Stimulators Price (2013-2018)
11 Global Pulmonary Hypertension Drug Market Segment by Application
11.1 Global Pulmonary Hypertension Drug Sales Market Share by Application (2013-2018)
11.2 Early-stage Drug Candidates (Phase I & Phase II) Sales Growth (2013-2018)
11.3 Late-stage Drug Candidates (Phase III & Registration Phase) Sales Growth (2013-2018)
12 Pulmonary Hypertension Drug Market Forecast (2018-2023)
12.1 Global Pulmonary Hypertension Drug Sales, Revenue and Growth Rate (2018-2023)
12.2 Pulmonary Hypertension Drug Market Forecast by Regions (2018-2023)
12.2.1 North America Pulmonary Hypertension Drug Market Forecast (2018-2023)
12.2.2 Europe Pulmonary Hypertension Drug Market Forecast (2018-2023)
12.2.3 Asia-Pacific Pulmonary Hypertension Drug Market Forecast (2018-2023)
12.2.4 South America Pulmonary Hypertension Drug Market Forecast (2018-2023)
12.2.5 Middle East and Africa Pulmonary Hypertension Drug Market Forecast (2018-2023)
12.3 Pulmonary Hypertension Drug Market Forecast by Type (2018-2023)
12.3.1 Global Pulmonary Hypertension Drug Sales Forecast by Type (2018-2023)
12.3.2 Global Pulmonary Hypertension Drug Market Share Forecast by Type (2018-2023)
12.4 Pulmonary Hypertension Drug Market Forecast by Application (2018-2023)
12.4.1 Global Pulmonary Hypertension Drug Sales Forecast by Application (2018-2023)
12.4.2 Global Pulmonary Hypertension Drug Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Pulmonary Hypertension Drug Picture
Table Product Specifications of Pulmonary Hypertension Drug
Figure Global Sales Market Share of Pulmonary Hypertension Drug by Types in 2017
Table Pulmonary Hypertension Drug Types for Major Manufacturers
Figure Prostacyclin and Prostacyclin Analogs Picture
Figure Endothelin Receptor Antagonists Picture
Figure Phosphodiesterase-5 Inhibitors Picture
Figure Soluble Guanylate Cyclase Stimulators Picture
Figure Pulmonary Hypertension Drug Sales Market Share by Applications in 2017
Figure Early-stage Drug Candidates (Phase I & Phase II) Picture
Figure Late-stage Drug Candidates (Phase III & Registration Phase) Picture
Figure United States Pulmonary Hypertension Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Canada Pulmonary Hypertension Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico Pulmonary Hypertension Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Germany Pulmonary Hypertension Drug Revenue (Value) and Growth Rate (2013-2023)
Figure France Pulmonary Hypertension Drug Revenue (Value) and Growth Rate (2013-2023)
Figure UK Pulmonary Hypertension Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Russia Pulmonary Hypertension Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Italy Pulmonary Hypertension Drug Revenue (Value) and Growth Rate (2013-2023)
Figure China Pulmonary Hypertension Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Japan Pulmonary Hypertension Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Korea Pulmonary Hypertension Drug Revenue (Value) and Growth Rate (2013-2023)
Figure India Pulmonary Hypertension Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia Pulmonary Hypertension Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil Pulmonary Hypertension Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt Pulmonary Hypertension Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia Pulmonary Hypertension Drug Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa Pulmonary Hypertension Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria Pulmonary Hypertension Drug Revenue (Value) and Growth Rate (2013-2023)
Table GlaxoSmithKline plc Basic Information, Manufacturing Base and Competitors
Table GlaxoSmithKline plc Pulmonary Hypertension Drug Type and Applications
Table GlaxoSmithKline plc Pulmonary Hypertension Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Novartis AG Basic Information, Manufacturing Base and Competitors
Table Novartis AG Pulmonary Hypertension Drug Type and Applications
Table Novartis AG Pulmonary Hypertension Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Merck & Co., Inc. Basic Information, Manufacturing Base and Competitors
Table Merck & Co., Inc. Pulmonary Hypertension Drug Type and Applications
Table Merck & Co., Inc. Pulmonary Hypertension Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Abbott Laboratories Basic Information, Manufacturing Base and Competitors
Table Abbott Laboratories Pulmonary Hypertension Drug Type and Applications
Table Abbott Laboratories Pulmonary Hypertension Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Boehringer Ingelheim GmbH Basic Information, Manufacturing Base and Competitors
Table Boehringer Ingelheim GmbH Pulmonary Hypertension Drug Type and Applications
Table Boehringer Ingelheim GmbH Pulmonary Hypertension Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table AstraZeneca plc Basic Information, Manufacturing Base and Competitors
Table AstraZeneca plc Pulmonary Hypertension Drug Type and Applications
Table AstraZeneca plc Pulmonary Hypertension Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table F. Hoffmann-La Roche AG Basic Information, Manufacturing Base and Competitors
Table F. Hoffmann-La Roche AG Pulmonary Hypertension Drug Type and Applications
Table F. Hoffmann-La Roche AG Pulmonary Hypertension Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Teva Pharmaceutical Industries Ltd. Basic Information, Manufacturing Base and Competitors
Table Teva Pharmaceutical Industries Ltd. Pulmonary Hypertension Drug Type and Applications
Table Teva Pharmaceutical Industries Ltd. Pulmonary Hypertension Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Vectura Group plc Basic Information, Manufacturing Base and Competitors
Table Vectura Group plc Pulmonary Hypertension Drug Type and Applications
Table Vectura Group plc Pulmonary Hypertension Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Pfizer Inc. Basic Information, Manufacturing Base and Competitors
Table Pfizer Inc. Pulmonary Hypertension Drug Type and Applications
Table Pfizer Inc. Pulmonary Hypertension Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Global Pulmonary Hypertension Drug Sales by Manufacturer (2016-2017)
Figure Global Pulmonary Hypertension Drug Sales Market Share by Manufacturer in 2016
Figure Global Pulmonary Hypertension Drug Sales Market Share by Manufacturer in 2017
Table Global Pulmonary Hypertension Drug Revenue by Manufacturer (2016-2017)
Figure Global Pulmonary Hypertension Drug Revenue Market Share by Manufacturer in 2016
Figure Global Pulmonary Hypertension Drug Revenue Market Share by Manufacturer in 2017
Figure Top 3 Pulmonary Hypertension Drug Manufacturer (Revenue) Market Share in 2017
Figure Top 6 Pulmonary Hypertension Drug Manufacturer (Revenue) Market Share in 2017
Figure Global Pulmonary Hypertension Drug Sales and Growth Rate (2013-2018)
Figure Global Pulmonary Hypertension Drug Revenue and Growth Rate (2013-2018)
Table Global Pulmonary Hypertension Drug Sales by Regions (2013-2018)
Table Global Pulmonary Hypertension Drug Sales Market Share by Regions (2013-2018)
Table Global Pulmonary Hypertension Drug Revenue by Regions (2013-2018)
Figure Global Pulmonary Hypertension Drug Revenue Market Share by Regions in 2013
Figure Global Pulmonary Hypertension Drug Revenue Market Share by Regions in 2017
Figure North America Pulmonary Hypertension Drug Sales and Growth Rate (2013-2018)
Figure Europe Pulmonary Hypertension Drug Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Pulmonary Hypertension Drug Sales and Growth Rate (2013-2018)
Figure South America Pulmonary Hypertension Drug Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Pulmonary Hypertension Drug Sales and Growth Rate (2013-2018)
Figure North America Pulmonary Hypertension Drug Revenue and Growth Rate (2013-2018)
Table North America Pulmonary Hypertension Drug Sales by Countries (2013-2018)
Table North America Pulmonary Hypertension Drug Sales Market Share by Countries (2013-2018)
Figure North America Pulmonary Hypertension Drug Sales Market Share by Countries in 2013
Figure North America Pulmonary Hypertension Drug Sales Market Share by Countries in 2017
Table North America Pulmonary Hypertension Drug Revenue by Countries (2013-2018)
Table North America Pulmonary Hypertension Drug Revenue Market Share by Countries (2013-2018)
Figure North America Pulmonary Hypertension Drug Revenue Market Share by Countries in 2013
Figure North America Pulmonary Hypertension Drug Revenue Market Share by Countries in 2017
Figure United States Pulmonary Hypertension Drug Sales and Growth Rate (2013-2018)
Figure Canada Pulmonary Hypertension Drug Sales and Growth Rate (2013-2018)
Figure Mexico Pulmonary Hypertension Drug Sales and Growth Rate (2013-2018)
Figure Europe Pulmonary Hypertension Drug Revenue and Growth Rate (2013-2018)
Table Europe Pulmonary Hypertension Drug Sales by Countries (2013-2018)
Table Europe Pulmonary Hypertension Drug Sales Market Share by Countries (2013-2018)
Table Europe Pulmonary Hypertension Drug Revenue by Countries (2013-2018)
Figure Europe Pulmonary Hypertension Drug Revenue Market Share by Countries in 2016
Figure Europe Pulmonary Hypertension Drug Revenue Market Share by Countries in 2017
Figure Germany Pulmonary Hypertension Drug Sales and Growth Rate (2013-2018)
Figure UK Pulmonary Hypertension Drug Sales and Growth Rate (2013-2018)
Figure France Pulmonary Hypertension Drug Sales and Growth Rate (2013-2018)
Figure Russia Pulmonary Hypertension Drug Sales and Growth Rate (2013-2018)
Figure Italy Pulmonary Hypertension Drug Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Pulmonary Hypertension Drug Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Pulmonary Hypertension Drug Sales by Countries (2013-2018)
Table Asia-Pacific Pulmonary Hypertension Drug Sales Market Share by Countries (2013-2018)
Figure Asia-Pacific Pulmonary Hypertension Drug Sales Market Share by Countries 2017
Table Asia-Pacific Pulmonary Hypertension Drug Revenue by Countries (2013-2018)
Figure Asia-Pacific Pulmonary Hypertension Drug Revenue Market Share by Countries 2017
Figure China Pulmonary Hypertension Drug Sales and Growth Rate (2013-2018)
Figure Japan Pulmonary Hypertension Drug Sales and Growth Rate (2013-2018)
Figure Korea Pulmonary Hypertension Drug Sales and Growth Rate (2013-2018)
Figure India Pulmonary Hypertension Drug Sales and Growth Rate (2013-2018)
Figure Southeast Asia Pulmonary Hypertension Drug Sales and Growth Rate (2013-2018)
Figure South America Pulmonary Hypertension Drug Revenue and Growth Rate (2013-2018)
Table South America Pulmonary Hypertension Drug Sales by Countries (2013-2018)
Table South America Pulmonary Hypertension Drug Sales Market Share by Countries (2013-2018)
Figure South America Pulmonary Hypertension Drug Sales Market Share by Countries in 2017
Table South America Pulmonary Hypertension Drug Revenue by Countries (2013-2018)
Table South America Pulmonary Hypertension Drug Revenue Market Share by Countries (2013-2018)
Figure South America Pulmonary Hypertension Drug Revenue Market Share by Countries in 2017
Figure Brazil Pulmonary Hypertension Drug Sales and Growth Rate (2013-2018)
Figure Argentina Pulmonary Hypertension Drug Sales and Growth Rate (2013-2018)
Figure Colombia Pulmonary Hypertension Drug Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Pulmonary Hypertension Drug Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Pulmonary Hypertension Drug Sales by Countries (2013-2018)
Table Middle East and Africa Pulmonary Hypertension Drug Sales Market Share by Countries (2013-2018)
Figure Middle East and Africa Pulmonary Hypertension Drug Sales Market Share by Countries in 2017
Table Middle East and Africa Pulmonary Hypertension Drug Revenue by Countries (2013-2018)
Table Middle East and Africa Pulmonary Hypertension Drug Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Pulmonary Hypertension Drug Revenue Market Share by Countries in 2013
Figure Middle East and Africa Pulmonary Hypertension Drug Revenue Market Share by Countries in 2017
Figure Saudi Arabia Pulmonary Hypertension Drug Sales and Growth Rate (2013-2018)
Figure UAE Pulmonary Hypertension Drug Sales and Growth Rate (2013-2018)
Figure Egypt Pulmonary Hypertension Drug Sales and Growth Rate (2013-2018)
Figure Nigeria Pulmonary Hypertension Drug Sales and Growth Rate (2013-2018)
Figure South Africa Pulmonary Hypertension Drug Sales and Growth Rate (2013-2018)
Table Global Pulmonary Hypertension Drug Sales by Type (2013-2018)
Table Global Pulmonary Hypertension Drug Sales Share by Type (2013-2018)
Table Global Pulmonary Hypertension Drug Revenue by Type (2013-2018)
Table Global Pulmonary Hypertension Drug Revenue Share by Type (2013-2018)
Figure Global Prostacyclin and Prostacyclin Analogs Sales Growth (2013-2018)
Figure Global Prostacyclin and Prostacyclin Analogs Price (2013-2018)
Figure Global Endothelin Receptor Antagonists Sales Growth (2013-2018)
Figure Global Endothelin Receptor Antagonists Price (2013-2018)
Figure Global Phosphodiesterase-5 Inhibitors Sales Growth (2013-2018)
Figure Global Phosphodiesterase-5 Inhibitors Price (2013-2018)
Figure Global Soluble Guanylate Cyclase Stimulators Sales Growth (2013-2018)
Figure Global Soluble Guanylate Cyclase Stimulators Price (2013-2018)
Table Global Pulmonary Hypertension Drug Sales by Application (2013-2018)
Table Global Pulmonary Hypertension Drug Sales Share by Application (2013-2018)
Figure Global Late-stage Drug Candidates (Phase III & Registration Phase) Sales Growth (2013-2018)
Figure Global Pulmonary Hypertension Drug Sales, Revenue and Growth Rate (2018-2023)
Table Global Pulmonary Hypertension Drug Sales Forecast by Regions (2018-2023)
Table Global Pulmonary Hypertension Drug Market Share Forecast by Regions (2018-2023)
Figure North America Sales Pulmonary Hypertension Drug Market Forecast (2018-2023)
Figure Europe Sales Pulmonary Hypertension Drug Market Forecast (2018-2023)
Figure Asia-Pacific Sales Pulmonary Hypertension Drug Market Forecast (2018-2023)
Figure South America Sales Pulmonary Hypertension Drug Market Forecast (2018-2023)
Figure Middle East and Africa Sales Pulmonary Hypertension Drug Market Forecast (2018-2023)
Table Global Pulmonary Hypertension Drug Sales Forecast by Type (2018-2023)
Table Global Pulmonary Hypertension Drug Market Share Forecast by Type (2018-2023)
Table Global Pulmonary Hypertension Drug Sales Forecast by Application (2018-2023)
Table Global Pulmonary Hypertension Drug Market Share Forecast by Application (2018-2023)
Table Distributors/Traders/ Dealers List
  • Global Herceptin Biosimilar Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
    Published: 18-Jun-2019        Price: US 3480 Onwards        Pages: 123
    Herceptin is the cancer medication used in the treatment of the breast cancer. It is monoclonal antibodies and are used along with the chemotherapy drugs. It is also termed as a targeted therapy drug. Trastuzumab is the one of the brand name herceptin which is administered by slow injection to a vein. Scope of the Report: The worldwide market for Herceptin Biosimilar is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, fr......
  • Global Cancer Immunotherapy Drug Discovery Outsourcing Market 2019 by Company, Regions, Type and Application, Forecast to 2024
    Published: 18-Jun-2019        Price: US 3480 Onwards        Pages: 116
    Scope of the Report: The global Cancer Immunotherapy Drug Discovery Outsourcing market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions. North America, especially The United States, will still play an important role which cannot be ignored. ......
  • Global Antibiotic Resistance Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
    Published: 18-Jun-2019        Price: US 3480 Onwards        Pages: 116
    Antibiotic are medicines that are used to prevent various bacterial infections and antibiotic resistance is the inability of a microorganism to withstand the effects of an antibiotic. It is a specific type of drug resistance. These bacteria may infect humans and animals body, and the infections they cause are harder to treat than those caused by non-resistant bacteria. Hence, antibiotic resistance leads to higher medical costs and increased mortality. Scope of the Report: T......
  • Global Neuroendocrine Tumors (NETs) Treatment Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
    Published: 18-Jun-2019        Price: US 3480 Onwards        Pages: 119
    Neuro Emotional Technique (NET) is a psycho-emotional therapy based on the physiological foundations of stress-related responses. As discovered in the late 1970's, emotional responses are composed of neuropeptides (amino acid chains) and their receptors, which lie on neurons and other cells of remote tissues in the body. The neuropeptides are ejected from the neuron and carry the encoded "information" to other sites within the body. These neuropeptides are in a category of neurochemicals known a......
  • Global Cervical Cancer Treatment Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
    Published: 18-Jun-2019        Price: US 3480 Onwards        Pages: 121
    Scope of the Report: The worldwide market for Cervical Cancer Treatment is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Cervical Cancer Treatment in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, reg......
  • Global Nasal Drug Delivery Technology Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
    Published: 18-Jun-2019        Price: US 3480 Onwards        Pages: 139
    Scope of the Report: The worldwide market for Nasal Drug Delivery Technology is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Nasal Drug Delivery Technology in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufact......
  • Global Pharmacovigilance (PV) Outsourcing Market 2019 by Company, Regions, Type and Application, Forecast to 2024
    Published: 18-Jun-2019        Price: US 3480 Onwards        Pages: 135
    Scope of the Report: The global Pharmacovigilance (PV) Outsourcing market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions. North America, especially The United States, will still play an important role which cannot be ignored. Any changes f......
  • Global Biopharmaceutical Excipients Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
    Published: 18-Jun-2019        Price: US 3480 Onwards        Pages: 120
    Scope of the Report: The worldwide market for Biopharmaceutical Excipients is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Biopharmaceutical Excipients in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturer......
  • Global API Contract Manufacturing Market 2019 by Company, Regions, Type and Application, Forecast to 2024
    Published: 18-Jun-2019        Price: US 3480 Onwards        Pages: 117
    Contract manufacturing is the process where manufacturer engages into an agreement with the companies for component or product manufacturing. Active pharmaceutical ingredient (API) contract manufacturing refers to the development of pharmaceutical drugs through contract manufacturing by outsourcing to other companies. Scope of the Report: The global API Contract Manufacturing market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 20......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs